GLP-1 patches vs GLP-1 shots

GLP-1 patches list no GLP-1 drug. A 2026 review of 25 such products found labels listing plant and nutrient ingredients, most often berberine, glutamine, cinnamon and pomegranate, with no lab analysis posted for any of them (Annals of Pharmacotherapy, 2026). FDA has approved no GLP-1 patch.

GLP-1 shots contain the drug itself. In STEP 1, adults on weekly brand semaglutide 2.4 mg lost an average of 14.9% of their body weight over 68 weeks, against 2.4% on placebo (NEJM, 2021). Arbor's weekly semaglutide is compounded and not FDA approved, starts at $99 a month, and begins with a physician review. A patch costs less and needs no needle. Those are its only advantages.

Searches for "glp 1 patch" and "glp 1 patch vs injection" often come from people who want the drug without the needle. An over-the-counter patch cannot offer that, because no GLP-1 drug is listed on its label.

Scroll the table sideways to see both columns →

A GLP-1 patch and a GLP-1 shot share a name and little else.

What is actually in a GLP-1 patch

Researchers at the University of Connecticut School of Pharmacy identified 24 patches and 1 gel sold as natural GLP-1 products, with an average of 7 listed ingredients each. Berberine, glutamine or glutamate, cinnamon and pomegranate appeared most often. None posted a certificate of analysis, the lab report that confirms what a product contains, and many left off the FDA disclaimer that supplement label claims require.

In March 2026, FDA sent an FDA warning letter on a patch to an online seller of a microneedle patch marketed for weight loss. The listing described "a blend of fat-burning ingredients (such as caffeine, green tea extract, or other thermogenic compounds)" and named type 2 diabetes treatment, weight loss and cardiovascular protection as its uses. FDA based the letter on that labeling and called the product an unapproved new drug. The letter does not say the patch contains a GLP-1 drug, and it reports no lab test of what is inside.

There is no Ozempic patch either. Ozempic is semaglutide, sold as a weekly pen and as tablets, and Drugs@FDA lists no skin form of it.

How each one works in the body

Semaglutide is a GLP-1 analogue with 94% sequence homology to human GLP-1. It binds the GLP-1 receptor, which helps regulate appetite and food intake, and its half-life of about a week allows once-weekly dosing (Wegovy prescribing information). Tirzepatide acts on both the GIP and GLP-1 receptors, with a half-life of about 5 days (Zepbound prescribing information).

A patch has to get through skin first. The outer skin layer keeps out most large molecules, and a 2000 dermatology review found every drug then used in transdermal delivery weighed under 500 daltons (Bos and Meinardi, 2000). Semaglutide weighs about 4,114 daltons and tirzepatide about 4,814, more than eight times that limit.

Berberine, at about 336 daltons, is small enough that size alone does not rule it out. What is missing is a human trial showing a patch delivers it into the blood or changes weight. True semaglutide microneedle patches, which push the drug past the outer skin layer, are in testing, but the work is early: research in rats, and a Phase 1 study in people that started in June 2026 and is still recruiting (ClinicalTrials.gov NCT07673900).

What the evidence shows

STEP 1, the source of that 14.9% figure, enrolled 1,961 adults without diabetes for 68 weeks. In SURMOUNT-1, 2,539 adults on brand tirzepatide lost 15.0% to 20.9% by dose over 72 weeks, against 3.1% on placebo (NEJM, 2022). The drug makers funded both trials, which tested brand products, not compounded semaglutide or tirzepatide.

PubMed lists no randomized trial of an over-the-counter GLP-1 or berberine patch for weight loss. The closest evidence is for berberine swallowed as a supplement, where a 2020 meta-analysis of 12 randomized trials found an average of 2.07 kg more weight lost than with control (Clin Nutr ESPEN, 2020). For the full comparison, see berberine vs Ozempic explained.

Prescription & FDA status

Drugs@FDA lists every approved GLP-1 medicine, from semaglutide and tirzepatide to liraglutide, dulaglutide and orforglipron, as an injection or a tablet, and each needs a prescription (Drugs@FDA). None is a patch.

Patches are often marketed as supplements, which FDA does not approve before sale, but they do not fit that category either. FDA says dietary supplements "must be swallowed," so topical products are not supplements (FDA).

Compounded semaglutide and tirzepatide are not FDA approved, and FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed (FDA). FDA declared the tirzepatide shortage resolved in December 2024 and the semaglutide shortage in February 2025, and the grace periods for compounders ended in 2025 (FDA).

Cost per month

Patches look cheap. NBC Connecticut reported in September 2025 that they can cost less than $1 a patch (NBC Connecticut), a price that buys no posted lab analysis and no trial.

Arbor lists compounded semaglutide from $99 a month and compounded tirzepatide from $149 a month. Neither is FDA approved. Each price covers medication, clinician care and check-ins and does not rise with your dose. The explainer on why compounded medications cost less covers why compounded prices sit below brand list prices.

GLP 1 shots are the option when you want a medicine that acts on the GLP-1 receptor. A retail patch is not a GLP 1 injection in another form.

Arbor compounded semaglutide is a weekly shot at a flat monthly price, and it is not FDA approved. A board-certified physician reviews your health history first, and if it is not the right fit, you are not charged.

A weekly shot may suit you when:

• You want a medicine with large weight trials behind its molecule
• Your BMI is 30 or higher, or 27 or higher with a weight-related condition, and you want a medically supervised plan
• You want a clinician to set and adjust your dose
• One small injection a week fits your routine

A patch may appeal to you only when:

• Avoiding a needle matters more to you than any proven effect
• You accept that no lab report or trial shows what the patch contains or does

To see whether a prescription fits, you can start GLP-1 shots with Arbor by taking a short eligibility quiz.

Online GLP-1 patch reviews cannot answer the question most buyers have. Star ratings and testimonials do not show what is inside a patch, whether anything crosses the skin, or how much weight people would have lost without it. The 2026 review found 1- and 2-star ratings on several products, with comments suggesting the patches did not work. The warning letter quoted a listing that posted "user survey" results above 97% for each claimed use, and FDA still called that patch an unapproved new drug.

A GLP-1 shot is judged by placebo-controlled trials instead. Compounded shots are not FDA approved, and a physician decides whether one fits you.